PubMed:9570512
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1663-1666 | gene:5328 | denotes | ATF |
| T1 | 1816-1819 | disease:C0019693 | denotes | HIV |
| T2 | 1663-1666 | gene:2668 | denotes | ATF |
| T3 | 1816-1819 | disease:C0019693 | denotes | HIV |
| T4 | 1707-1712 | gene:51176 | denotes | LEF-1 |
| T5 | 1816-1819 | disease:C0019693 | denotes | HIV |
| R1 | T0 | T1 | associated_with | ATF,HIV |
| R2 | T2 | T3 | associated_with | ATF,HIV |
| R3 | T4 | T5 | associated_with | LEF-1,HIV |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-69 | DNA | denotes | Human immunodeficiency virus type 1 long terminal repeat quasispecies |
| T2 | 104-118 | protein | denotes | nuclear factor |
| T3 | 134-167 | cell_type | denotes | human glial cells and lymphocytes |
| T4 | 326-341 | DNA | denotes | proviral genome |
| T5 | 391-411 | DNA | denotes | long terminal repeat |
| T6 | 413-416 | DNA | denotes | LTR |
| T7 | 440-457 | DNA | denotes | LTR-directed gene |
| T8 | 557-561 | DNA | denotes | LTRs |
| T9 | 567-579 | DNA | denotes | proviral DNA |
| T10 | 583-614 | cell_type | denotes | HIV-1-infected peripheral blood |
| T11 | 646-650 | DNA | denotes | LTRs |
| T12 | 778-785 | DNA | denotes | LAI LTR |
| T13 | 798-814 | DNA | denotes | 455-bp U3 region |
| T14 | 924-928 | DNA | denotes | LTRs |
| T15 | 980-987 | DNA | denotes | LAI LTR |
| T16 | 991-1005 | cell_line | denotes | U-373 MG cells |
| T17 | 1010-1031 | cell_line | denotes | astrocytoma cell line |
| T18 | 1047-1059 | cell_line | denotes | Jurkat cells |
| T19 | 1063-1096 | cell_line | denotes | CD4-positive lymphocyte cell line |
| T20 | 1105-1109 | DNA | denotes | LTRs |
| T21 | 1155-1169 | cell_line | denotes | U-373 MG cells |
| T22 | 1220-1224 | DNA | denotes | LTRs |
| T23 | 1255-1267 | cell_line | denotes | Jurkat cells |
| T24 | 1289-1296 | DNA | denotes | LAI LTR |
| T25 | 1313-1325 | DNA | denotes | LTR sequence |
| T26 | 1394-1410 | DNA | denotes | cis-acting sites |
| T27 | 1422-1431 | DNA | denotes | U3 region |
| T28 | 1439-1442 | DNA | denotes | LTR |
| T29 | 1565-1585 | protein | denotes | transcription factor |
| T30 | 1600-1685 | DNA | denotes | activating transcription factor/cAMP response element binding (ATF/CREB) binding site |
| T31 | 1707-1768 | DNA | denotes | LEF-1 and distal NF-kappaB transcription factor binding sites |
| T32 | 1816-1825 | DNA | denotes | HIV-1 LTR |
| T33 | 1855-1867 | DNA | denotes | LTR sequence |
| T34 | 1907-1910 | DNA | denotes | LTR |
| T35 | 1924-1944 | protein | denotes | transcription factor |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T6 | 326-341 | DNA_molecule | denotes | proviral genome |
| T1 | 0-35 | virus | denotes | Human immunodeficiency virus type 1 |
| T2 | 36-56 | DNA_domain_or_region | denotes | long terminal repeat |
| T3 | 80-99 | other_name | denotes | basal transcription |
| T4 | 104-118 | protein_family_or_group | denotes | nuclear factor |
| T5 | 279-284 | virus | denotes | HIV-1 |
| T7 | 391-411 | DNA_domain_or_region | denotes | long terminal repeat |
| T8 | 413-416 | DNA_domain_or_region | denotes | LTR |
| T9 | 440-443 | DNA_domain_or_region | denotes | LTR |
| T10 | 485-507 | body_part | denotes | central nervous system |
| T11 | 509-512 | body_part | denotes | CNS |
| T12 | 518-531 | body_part | denotes | immune system |
| T13 | 557-561 | DNA_domain_or_region | denotes | LTRs |
| T14 | 567-579 | DNA_family_or_group | denotes | proviral DNA |
| T15 | 583-588 | virus | denotes | HIV-1 |
| T16 | 616-633 | other_name | denotes | Sequence analysis |
| T17 | 646-650 | DNA_domain_or_region | denotes | LTRs |
| T18 | 687-695 | multi_cell | denotes | patients |
| T19 | 719-721 | other_name | denotes | 33 |
| T20 | 722-732 | nucleotide | denotes | nucleotide |
| T21 | 778-781 | DNA_domain_or_region | denotes | LAI |
| T22 | 782-785 | DNA_domain_or_region | denotes | LTR |
| T23 | 798-814 | DNA_domain_or_region | denotes | 455-bp U3 region |
| T24 | 816-845 | other_name | denotes | Transient expression analyses |
| T25 | 924-928 | DNA_domain_or_region | denotes | LTRs |
| T26 | 980-983 | DNA_domain_or_region | denotes | LAI |
| T27 | 984-987 | DNA_domain_or_region | denotes | LTR |
| T28 | 991-1005 | cell_line | denotes | U-373 MG cells |
| T29 | 1010-1021 | cell_type | denotes | astrocytoma |
| T30 | 1047-1059 | cell_line | denotes | Jurkat cells |
| T31 | 1063-1075 | cell_line | denotes | CD4-positive |
| T32 | 1076-1086 | cell_type | denotes | lymphocyte |
| T33 | 1105-1109 | DNA_domain_or_region | denotes | LTRs |
| T34 | 1155-1169 | cell_line | denotes | U-373 MG cells |
| T35 | 1220-1224 | DNA_domain_or_region | denotes | LTRs |
| T36 | 1255-1267 | cell_line | denotes | Jurkat cells |
| T37 | 1289-1292 | DNA_domain_or_region | denotes | LAI |
| T38 | 1293-1296 | DNA_domain_or_region | denotes | LTR |
| T39 | 1313-1316 | DNA_domain_or_region | denotes | LTR |
| T40 | 1358-1390 | other_name | denotes | transcription factor recruitment |
| T41 | 1394-1410 | DNA_domain_or_region | denotes | cis-acting sites |
| T42 | 1422-1431 | DNA_domain_or_region | denotes | U3 region |
| T43 | 1439-1442 | DNA_domain_or_region | denotes | LTR |
| T44 | 1463-1500 | other_name | denotes | electrophoretic mobility shift assays |
| T45 | 1537-1555 | other_name | denotes | sequence variation |
| T46 | 1565-1585 | protein_family_or_group | denotes | transcription factor |
| T47 | 1600-1632 | protein_molecule | denotes | activating transcription factor/ |
| T48 | 1632-1636 | polynucleotide | denotes | cAMP |
| T49 | 1663-1671 | protein_molecule | denotes | ATF/CREB |
| T50 | 1707-1712 | protein_molecule | denotes | LEF-1 |
| T51 | 1724-1733 | protein_family_or_group | denotes | NF-kappaB |
| T52 | 1816-1821 | virus | denotes | HIV-1 |
| T53 | 1822-1825 | DNA_domain_or_region | denotes | LTR |
| T54 | 1855-1858 | DNA_domain_or_region | denotes | LTR |
| T55 | 1901-1906 | other_name | denotes | basal |
| T56 | 1907-1910 | DNA_domain_or_region | denotes | LTR |
| T57 | 1924-1944 | protein_family_or_group | denotes | transcription factor |
| T58 | 1998-2015 | other_name | denotes | viral replication |
| T59 | 2028-2031 | body_part | denotes | CNS |
| T60 | 2036-2049 | body_part | denotes | immune system |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 391-436 | NP | denotes | long terminal repeat (LTR) sequence diversity |
| C2 | 481-513 | NP | denotes | the central nervous system (CNS) |
| C3 | 557-561 | NP | denotes | LTRs |
| C4 | 637-695 | NP | denotes | nineteen LTRs cloned from 2 adult and 3 pediatric patients |
| C5 | 794-814 | NP | denotes | the 455-bp U3 region |
| C6 | 910-928 | NP | denotes | some of these LTRs |
| C7 | 933-943 | NP | denotes | activities |
| C8 | 944-949 | NP | denotes | which |
| C10 | 991-1005 | NP | denotes | U-373 MG cells |
| C9 | 976-1005 | NP | denotes | the LAI LTR in U-373 MG cells |
| C11 | 1047-1059 | NP | denotes | Jurkat cells |
| C13 | 1105-1109 | NP | denotes | LTRs |
| C14 | 1110-1115 | NP | denotes | which |
| C12 | 1105-1151 | NP | denotes | LTRs which demonstrated the highest activities |
| C15 | 1155-1169 | NP | denotes | U-373 MG cells |
| C16 | 1216-1224 | NP | denotes | the LTRs |
| C17 | 1255-1267 | NP | denotes | Jurkat cells |
| C18 | 1285-1296 | NP | denotes | the LAI LTR |
| C19 | 1298-1325 | NP | denotes | Differences in LTR sequence |
| C21 | 1435-1442 | NP | denotes | the LTR |
| C20 | 1418-1442 | NP | denotes | the U3 region of the LTR |
| C22 | 1597-1685 | NP | denotes | an activating transcription factor/cAMP response element binding (ATF/CREB) binding site |
| C23 | 1770-1774 | NP | denotes | that |
| C24 | 1855-1875 | NP | denotes | LTR sequence changes |
| C25 | 1901-1956 | NP | denotes | basal LTR function and transcription factor recruitment |
| C26 | 1958-1963 | NP | denotes | which |
| C27 | 2028-2031 | NP | denotes | CNS |
| R1 | C4 | C3 | coref-ident | nineteen LTRs cloned from 2 adult and 3 pediatric patients,LTRs |
| R2 | C6 | C4 | coref-ident | some of these LTRs,nineteen LTRs cloned from 2 adult and 3 pediatric patients |
| R3 | C8 | C7 | coref-relat | which,activities |
| R4 | C13 | C6 | coref-ident | LTRs,some of these LTRs |
| R5 | C14 | C13 | coref-relat | which,LTRs |
| R6 | C15 | C10 | coref-ident | U-373 MG cells,U-373 MG cells |
| R7 | C16 | C12 | coref-ident | the LTRs,LTRs which demonstrated the highest activities |
| R8 | C17 | C11 | coref-ident | Jurkat cells,Jurkat cells |
| R9 | C18 | C9 | coref-ident | the LAI LTR,the LAI LTR in U-373 MG cells |
| R10 | C19 | C1 | coref-ident | Differences in LTR sequence,long terminal repeat (LTR) sequence diversity |
| R11 | C21 | C16 | coref-ident | the LTR,the LTRs |
| R12 | C20 | C5 | coref-ident | the U3 region of the LTR,the 455-bp U3 region |
| R13 | C23 | C22 | coref-relat | that,an activating transcription factor/cAMP response element binding (ATF/CREB) binding site |
| R14 | C24 | C19 | coref-ident | LTR sequence changes,Differences in LTR sequence |
| R15 | C26 | C25 | coref-relat | which,basal LTR function and transcription factor recruitment |
| R16 | C27 | C2 | coref-ident | CNS,the central nervous system (CNS) |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-168 | Sentence | denotes | Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. |
| S2 | 169-342 | Sentence | denotes | The generation of genomic diversity during the course of infection has the potential to affect all aspects of HIV-1 replication, including expression of the proviral genome. |
| S3 | 343-615 | Sentence | denotes | To gain a better understanding of the impact of long terminal repeat (LTR) sequence diversity on LTR-directed gene expression in cells of the central nervous system (CNS) and immune system, we amplified and cloned LTRs from proviral DNA in HIV-1-infected peripheral blood. |
| S4 | 616-815 | Sentence | denotes | Sequence analysis of nineteen LTRs cloned from 2 adult and 3 pediatric patients revealed an average of 33 nucleotide changes (with respect to the sequence of the LAI LTR) within the 455-bp U3 region. |
| S5 | 816-1098 | Sentence | denotes | Transient expression analyses in cells of neuroglial and lymphocytic origin demonstrated that some of these LTRs had activities which varied significantly from the LAI LTR in U-373 MG cells (an astrocytoma cell line) as well as in Jurkat cells (a CD4-positive lymphocyte cell line). |
| S6 | 1099-1297 | Sentence | denotes | While LTRs which demonstrated the highest activities in U-373 MG cells also yielded high activities in Jurkat cells, the LTRs were generally more active in Jurkat cells when compared to the LAI LTR. |
| S7 | 1298-1501 | Sentence | denotes | Differences in LTR sequence also resulted in differences in transcription factor recruitment to cis-acting sites within the U3 region of the LTR, as demonstrated by electrophoretic mobility shift assays. |
| S8 | 1502-1826 | Sentence | denotes | In particular, naturally occurring sequence variation impacted transcription factor binding to an activating transcription factor/cAMP response element binding (ATF/CREB) binding site (located between the LEF-1 and distal NF-kappaB transcription factor binding sites) that we identified in previous studies of the HIV-1 LTR. |
| S9 | 1827-2057 | Sentence | denotes | These findings suggest that LTR sequence changes can significantly affect basal LTR function and transcription factor recruitment, which may, in turn, alter the course of viral replication in cells of CNS and immune system origin. |